Root Financial Partners’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$329 Buy
+23
New +$299 ﹤0.01% 3372
2026
Q2
– Sell
-11
Closed -$102 – 1343
2026
Q1
$102 Buy
+11
New +$96 ﹤0.01% 3278

Other funds holding FDMT

Root Financial Partners's FDMT Position: Q3 2026 in Review

Root Financial Partners opened a new position in 4D Molecular Therapeutics (FDMT) in Q3 2026: 23 shares worth $329. The stake represents ﹤0.01% of the portfolio and ranks #3372 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in FDMT as recently as Q1 2026.

Root Financial Partners first reported a position in FDMT in Q1 2026 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.

  • Root Financial Partners held 23 shares of 4D Molecular Therapeutics worth $329 as of Q3 2026.
  • 4D Molecular Therapeutics was a new Root Financial Partners position in Q3 2026.
  • 4D Molecular Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3372 holding.
  • Root Financial Partners first reported a position in 4D Molecular Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 167 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.